AirSculpt Technologies, Inc. (AIRS)

Market Cap	395.85M
Revenue (ttm)	157.55M
Net Income (ttm)	-17.98M
Shares Out	62.44M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	317.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,521,616
Open	6.01
Previous Close	6.12
Day's Range	6.01 - 6.70
52-Week Range	1.53 - 12.00
Beta	2.61
Analysts	Hold
Price Target	3.75 (-40.85%)
Earnings Date	Nov 7, 2025

About AIRS

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States, Canada, and the United Kingdom. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and Air...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Oct 29, 2021
• Employees: 422
• Stock Exchange: NASDAQ
• Ticker Symbol: AIRS
• Website: https://airsculpt.com

Financial Performance

In 2024, AirSculpt Technologies's revenue was $180.35 million, a decrease of -7.95% compared to the previous year's $195.92 million. Losses were -$8.25 million, 84.2% more than in 2023.

Analyst Summary

According to 2 analysts, the average rating for AIRS stock is "Hold." The 12-month stock price target is $3.75, which is a decrease of -40.85% from the latest price.

Price Target

$3.75

(-40.85% downside)

Analyst Consensus: Hold